跳至主要内容
临床试验/NCT02940444
NCT02940444Unknown1 期

Safety and Efficacy of Preoperative Administration of Heparin as Thromboprophylaxis in Major Thoracic Surgery

West China Hospital1 个研究点 分布在 1 个国家目标入组 2,000 人开始时间: 2016年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
入组人数
2,000
试验地点
1
主要终点
INR

研究概览

简要总结

Thromboembolism is an important perioperative complication in major thoracic surgery, even though current guidelines have recommended postoperative administration of heparin or LMWH for thromboprophylaxis for those high-risk patients, there are still many cases of thromboembolism. Therefore, as the guideline itself writes, the investigators believe the rational of dose and timing of heparin in thoracic surgery are still not well established. Therefore, the investigators aimed to conduct this randomized controlled study to explore the safety and efficacy of preoperative Administration of Heparin as Thromboprophylaxis in Major Thoracic Surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18-75 years old without any preoperative VTEs;
  • patients undergoing major thoracic surgery (including lobectomy, esophagectomy, and thymectomy).

排除标准

  • patients with coagulation disorders: preoperative international normalized ratio (INR) > 1.5, or blood platelet count < 50x10^9/L;
  • patients receiving any therapeutic anticoagulation preoperatively;
  • patients with severe renal or liver dysfunction.

研究组 & 干预措施

case group

Experimental

start heparin sodium (5000IU, BID) upon admission, and continue until discharge

干预措施: Heparin (Drug)

control group

Active Comparator

start heparin sodium (5000 IU,BID) from postoperative day 1, and continue until discharge

干预措施: Heparin (Drug)

结局指标

主要结局

INR

时间窗: on postoperative day 1 for both group

blood platlet count(/L)

时间窗: on postoperative day 1 for both group

chest tube drainage volume (ml)

时间窗: from postoperative day 1 to chest tube remove(usually on postoperative day 3 for lobectomy or thymectomy,on postoperative day 7 for esophagectomy )

APTT (s)

时间窗: on postoperative day 1 for both group

intraoperative bleeding volume (ml)

时间窗: the bleeding volume (ml) during operation in the operation room for all patients

During the operation, the blood loss of each patient was collected and measured, and recorded by the investigators.

PT(s)

时间窗: on postoperative day 1 for both group

thromboembolism occurence rate (%)

时间窗: within 30 days after surgery

chest tube drainage duration (days)

时间窗: from postoperative day 1 to chest tube remove(usually on postoperative day 3 for lobectomy or thymectomy,on postoperative day 7 for esophagectomy )

次要结局

  • PT(s)(rightly upon hospital admission day)
  • APTT(s)(rightly upon hospital admission day)
  • INR(rightly upon hospital admission day)
  • blood platlet count(/L)(rightly upon hospital admission day)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Yi-Dan Lin

proffessor

West China Hospital

研究点 (1)

Loading locations...

相似试验